数字健康干预和抑郁症药物治疗之间的成本效益比较:系统性审查
Jiae Im1, Byeong-Chan Oh1, Ha-Jun Song1
1School of Pharmacy, Sungkyunkwan University, Gyeonggi-do, Republic of Korea.
Journal of medical Internet research
|September 10, 2025
概括
对数字健康干预 (DHI) 和抑郁症药物治疗的经济评估有很大的不同. 医疗保健机构经常使用基于试验的研究,以短期结果,突出需要更好的成本和有效性测量.
科学领域:
- 卫生经济学 卫生经济学
- 数字健康干预措施 数字健康干预措施
- 药物治疗 药物治疗
- 抑郁症治疗 抑郁症治疗
背景情况:
- 数字健康干预措施 (DHIs) 的经济评估需要与药物治疗不同的定制方法.
- 在评估DHI的明确指导方针中存在很大的差距.
- 这项研究解决了对DHIs和抑郁症治疗中药物治疗的经济评估进行比较分析的需要.
研究的目的:
- 系统地审查和比较用于治疗抑郁症的DHI和药物治疗的经济评估文献.
- 为了确定两种干预类型之间的方法,成本组件和报告质量的差异.
主要方法:
- 系统的文学搜索欧维德的MEDLINE,Embase,Cochrane图书馆和PsycINFO (2013年1月至2023年10月).
- 纳入标准:评估抑郁症的DHI或药物治疗的研究,报告了经济结果.
- 关于研究特征,输入参数,建模组件的数据提取;使用Chi-square测试和定性比较进行分析;使用CHEERS检查清单进行质量评估.
主要成果:
- 包括 42 种物品: 23 种 DHI, 19 种药疗.
- 药物治疗更频繁地使用成本效益分析 (84%对52%) 和主动对照 (89%对22%).
- 医疗保健机构主要使用基于试验的研究 (74%),具有短期结果和较少定义的成本项目,而药物治疗研究更常以模型为基础 (68%),具有更长的时间视界和更高的报告质量.
结论:
- 与药物治疗相比,DHIs更频繁地使用基于试验的研究来评估短期结果和较少定义的成本项目.
- 这凸显了需要改进的测量和建模,以准确地捕捉DHI成本和有效性.
- 根据CHEERS检查清单,药物治疗研究通常显示报告质量更高.
更多相关视频
08:15Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
491
05:19Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment
Published on: July 7, 2023
3.2K
相关概念视频
Antidepressant Drugs: MAOIs and Other Agents
761
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
761
Depression: Overview
735
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
735
Drug Therapy
226
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
226
Antidepressant Drugs: Overview
1.3K
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
1.3K
Electroconvulsive Therapy
771
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
771
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
1.3K
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
1.3K
